Genetic characteristics of myoadenylate deaminase deficiency

Annals of Neurology

Volumn 44, Issue 1, 1998, Pages 140-143

  Verzijl, H T F M ^a   Van Engelen, B G M ^a   Luyten, J A F M ^a   Steenbergen, G C H ^a   Van Den Heuvel, L P W J ^a   Ter Laak, H J ^a   Padberg, G W ^a   Wevers, R A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE;

ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA DETERMINATION; DNA POLYMORPHISM; ENZYME DEFICIENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; NETHERLANDS; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AMP DEAMINASE; BASE SEQUENCE; BIOPSY; CHI-SQUARE DISTRIBUTION; DNA; EXERCISE TEST; HUMANS; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; POINT MUTATION; POLYMERASE CHAIN REACTION;

EID: 0031926570     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440124     Document Type: Article

References (16)

1. Fishbein WN, Armbrustmacher VW, Griffin JL. Myoadenylate deaminase deficiency: a new disease of muscle. Science 1978; 200:545-548
2. Fishbein WN. Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 1985;33:158-169
3. Morisaki T, Gross M, Morisaki H, et al. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 1992;89:6457-6461
4. Sabina RL, Fishbein WN, Pezeshkpour G, et al. Molecular analysis of the myoadenylate deaminase deficiencies. Neurology 1992;42:170-179
5. Shumate JB, Katnik R, Ruiz M, et al. Myoadenylate deaminase deficiency. Muscle Nerve 1979;2:213-216
6. Sinkeler SPT, Joosten EMG, Wevers RA, et al. Myoadenylate deaminase deficiency: a clinical and biochemical study in nine families. Muscle Nerve 1988;11:312-317
7. Kelemen J, Rice DR, Bradley WG, et al. Familial MAD deficiency and exertional myalgia. Neurology 1982;32:857-863
8. Fishbein WN, Griffin JL, Nagarayan K, et al. Immunologic uniqueness of muscle adenylate deaminase and genetic transmission of the deficiency state. Clin Res 1979;27:274A (Abstract)
9. Sabina RL, Holmes EW. Myoadenylate deaminase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited diseases, vol 2. 7th ed. New York: McGraw-Hill, 1995:1769-1780
10. Nagao H, Habara S, Morimoto T, et al. AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood: histochemical and biochemical studies. Neuropediatrics 1986;17:193-198
11. Kar NC, Pearson CM. Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy. Neurology 1973;33:478-482
12. Fishbein WN, Griffin JL, Armbrustmacher VW. Stain for skeletal muscle adenylate deaminase: an effective tetrazolium stain for frozen biopsy specimens. Arch Pathol Lab Med 1980;104: 462-466
13. Tsujino S, Shanske S, Carroll JE, et al. Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci. Neuromusc Disord 1995;5:263-266
14. Marin R, Connick E. Tension myalgia versus myoadenylate deaminase deficiency: a case report. Arch Phys Med Rehabil 1997;78:95-97
15. Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inherit Metab Dis 1997;20:186-192
16. Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve 1995; 18:239-241